List of Tables

Table 1. Raibizumab Biosimilars Consumption Value & CAGR: China VS Global, 2020-2031, US$ Million

Table 2. Raibizumab Biosimilars Market Restraints

Table 3. Raibizumab Biosimilars Market Trends

Table 4. Raibizumab Biosimilars Industry Policy

Table 5. Global Raibizumab Biosimilars Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 6. Global Raibizumab Biosimilars Revenue Share by Company, 2020-2025, Ranked by Data of 2024

Table 7. Global Raibizumab Biosimilars Sales Quantity by Company, (2020-2025) & (Units), Ranked Based on Sales in 2024

Table 8. Global Raibizumab Biosimilars Sales Quantity by Company, 2020-2025, Ranked by Data of 2024

Table 9. Global Raibizumab Biosimilars Average Selling Price (ASP) by Company, (2020-2025) & (K USD/Unit)

Table 10. Global Raibizumab Biosimilars Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Raibizumab Biosimilars Mergers & Acquisitions, Expansion Plans

Table 12. Global Raibizumab Biosimilars Manufacturers Product Type

Table 13. Head Office and Raibizumab Biosimilars Production Site of Key Manufacturer

Table 14. Raibizumab Biosimilars Capacity of Major Manufacturers and Future Plan

Table 15. China Raibizumab Biosimilars Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 16. China Raibizumab Biosimilars Revenue Share by Company, 2020-2025, Ranked by Data of 2024

Table 17. China Raibizumab Biosimilars Sales Quantity by Company, (2020-2025) & (Units), Ranked Based on Sales in 2024

Table 18. China Raibizumab Biosimilars Sales Quantity by Company, 2020-2025, Ranked by Data of 2024

Table 19. Global Raibizumab Biosimilars Production & Forecast by Region, 2020 VS 2024 VS 2031, (Units)

Table 20. Global Raibizumab Biosimilars Production by Region, 2020-2025, (Units)

Table 21. Global Raibizumab Biosimilars Production Forecast by Region, 2026-2031, (Units)

Table 22. Global Key Players of Raibizumab Biosimilars Upstream (Raw Materials)

Table 23. Global Raibizumab Biosimilars Typical Customers

Table 24. Raibizumab Biosimilars Typical Distributors

Table 25. by Type, Global Raibizumab Biosimilars Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 26. by Application, Global Raibizumab Biosimilars Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 27. By Region, Global Raibizumab Biosimilars Consumption Value, 2020 VS 2024 VS 2031, US$ Million

Table 28. By Region, Global Raibizumab Biosimilars Consumption Value, 2020-2031, US$ Million

Table 29. By Region, Global Raibizumab Biosimilars Sales Quantity, 2020-2031, (Units)

Table 30. By Country, Global Raibizumab Biosimilars Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 31. By Country, Global Raibizumab Biosimilars Consumption Value, 2020-2031, US$ Million

Table 32. By Country, Global Raibizumab Biosimilars Consumption Value Market Share, 2020-2031

Table 33. By Country, Global Raibizumab Biosimilars Sales Quantity, 2020-2031, (Units)

Table 34. By Country, Global Raibizumab Biosimilars Sales Quantity Market Share, 2020-2031

Table 35. Roche Company Information, Head Office, Market Area, and Industry Position

Table 36. Roche Raibizumab Biosimilars Models, Specifications, and Application

Table 37. Roche Raibizumab Biosimilars Sales Quantity (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin, 2020-2025

Table 38. Roche Company Profile and Main Business

Table 39. Roche Recent Developments

Table 40. Novartis Company Information, Head Office, Market Area, and Industry Position

Table 41. Novartis Raibizumab Biosimilars Models, Specifications, and Application

Table 42. Novartis Raibizumab Biosimilars Sales Quantity (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin, 2020-2025

Table 43. Novartis Company Profile and Main Business

Table 44. Novartis Recent Developments

Table 45. Genentech Company Information, Head Office, Market Area, and Industry Position

Table 46. Genentech Raibizumab Biosimilars Models, Specifications, and Application

Table 47. Genentech Raibizumab Biosimilars Sales Quantity (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin, 2020-2025

Table 48. Genentech Company Profile and Main Business

Table 49. Genentech Recent Developments

Table 50. Pfizer Company Information, Head Office, Market Area, and Industry Position

Table 51. Pfizer Raibizumab Biosimilars Models, Specifications, and Application

Table 52. Pfizer Raibizumab Biosimilars Sales Quantity (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin, 2020-2025

Table 53. Pfizer Company Profile and Main Business

Table 54. Pfizer Recent Developments

Table 55. Sartorius Company Information, Head Office, Market Area, and Industry Position

Table 56. Sartorius Raibizumab Biosimilars Models, Specifications, and Application

Table 57. Sartorius Raibizumab Biosimilars Sales Quantity (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin, 2020-2025

Table 58. Sartorius Company Profile and Main Business

Table 59. Sartorius Recent Developments

Table 60. Eli Lilly Company Information, Head Office, Market Area, and Industry Position

Table 61. Eli Lilly Raibizumab Biosimilars Models, Specifications, and Application

Table 62. Eli Lilly Raibizumab Biosimilars Sales Quantity (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin, 2020-2025

Table 63. Eli Lilly Company Profile and Main Business

Table 64. Eli Lilly Recent Developments

Table 65. Bayer Company Information, Head Office, Market Area, and Industry Position

Table 66. Bayer Raibizumab Biosimilars Models, Specifications, and Application

Table 67. Bayer Raibizumab Biosimilars Sales Quantity (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin, 2020-2025

Table 68. Bayer Company Profile and Main Business

Table 69. Bayer Recent Developments

Table 70. Amgen Company Information, Head Office, Market Area, and Industry Position

Table 71. Amgen Raibizumab Biosimilars Models, Specifications, and Application

Table 72. Amgen Raibizumab Biosimilars Sales Quantity (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin, 2020-2025

Table 73. Amgen Company Profile and Main Business

Table 74. Amgen Recent Developments

Table 75. PlantForm Company Information, Head Office, Market Area, and Industry Position

Table 76. PlantForm Raibizumab Biosimilars Models, Specifications, and Application

Table 77. PlantForm Raibizumab Biosimilars Sales Quantity (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin, 2020-2025

Table 78. PlantForm Company Profile and Main Business

Table 79. PlantForm Recent Developments

Table 80. PharmaPraxis Company Information, Head Office, Market Area, and Industry Position

Table 81. PharmaPraxis Raibizumab Biosimilars Models, Specifications, and Application

Table 82. PharmaPraxis Raibizumab Biosimilars Sales Quantity (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin, 2020-2025

Table 83. PharmaPraxis Company Profile and Main Business

Table 84. PharmaPraxis Recent Developments

Table 85. Samsung Bioepis Company Information, Head Office, Market Area, and Industry Position

Table 86. Samsung Bioepis Raibizumab Biosimilars Models, Specifications, and Application

Table 87. Samsung Bioepis Raibizumab Biosimilars Sales Quantity (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin, 2020-2025

Table 88. Samsung Bioepis Company Profile and Main Business

Table 89. Samsung Bioepis Recent Developments

Table 90. Centus Company Information, Head Office, Market Area, and Industry Position

Table 91. Centus Raibizumab Biosimilars Models, Specifications, and Application

Table 92. Centus Raibizumab Biosimilars Sales Quantity (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin, 2020-2025

Table 93. Centus Company Profile and Main Business

Table 94. Centus Recent Developments

Table 95. Cadila Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

Table 96. Cadila Pharmaceuticals Raibizumab Biosimilars Models, Specifications, and Application

Table 97. Cadila Pharmaceuticals Raibizumab Biosimilars Sales Quantity (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin, 2020-2025

Table 98. Cadila Pharmaceuticals Company Profile and Main Business

Table 99. Cadila Pharmaceuticals Recent Developments

Table 100. Dr Reddy's Company Information, Head Office, Market Area, and Industry Position

Table 101. Dr Reddy's Raibizumab Biosimilars Models, Specifications, and Application

Table 102. Dr Reddy's Raibizumab Biosimilars Sales Quantity (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin, 2020-2025

Table 103. Dr Reddy's Company Profile and Main Business

Table 104. Dr Reddy's Recent Developments

Table 105. Aurobindo Pharma Company Information, Head Office, Market Area, and Industry Position

Table 106. Aurobindo Pharma Raibizumab Biosimilars Models, Specifications, and Application

Table 107. Aurobindo Pharma Raibizumab Biosimilars Sales Quantity (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin, 2020-2025

Table 108. Aurobindo Pharma Company Profile and Main Business

Table 109. Aurobindo Pharma Recent Developments

Table 110. Biocad Company Information, Head Office, Market Area, and Industry Position

Table 111. Biocad Raibizumab Biosimilars Models, Specifications, and Application

Table 112. Biocad Raibizumab Biosimilars Sales Quantity (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin, 2020-2025

Table 113. Biocad Company Profile and Main Business

Table 114. Biocad Recent Developments

Table 115. MAbxience Company Information, Head Office, Market Area, and Industry Position

Table 116. MAbxience Raibizumab Biosimilars Models, Specifications, and Application

Table 117. MAbxience Raibizumab Biosimilars Sales Quantity (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin, 2020-2025

Table 118. MAbxience Company Profile and Main Business

Table 119. MAbxience Recent Developments

Table 120. Hetero Company Information, Head Office, Market Area, and Industry Position

Table 121. Hetero Raibizumab Biosimilars Models, Specifications, and Application

Table 122. Hetero Raibizumab Biosimilars Sales Quantity (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin, 2020-2025

Table 123. Hetero Company Profile and Main Business

Table 124. Hetero Recent Developments

Table 125. Biocon Company Information, Head Office, Market Area, and Industry Position

Table 126. Biocon Raibizumab Biosimilars Models, Specifications, and Application

Table 127. Biocon Raibizumab Biosimilars Sales Quantity (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin, 2020-2025

Table 128. Biocon Company Profile and Main Business

Table 129. Biocon Recent Developments

Table 130. Kirin Biologics Company Information, Head Office, Market Area, and Industry Position

Table 131. Kirin Biologics Raibizumab Biosimilars Models, Specifications, and Application

Table 132. Kirin Biologics Raibizumab Biosimilars Sales Quantity (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin, 2020-2025

Table 133. Kirin Biologics Company Profile and Main Business

Table 134. Kirin Biologics Recent Developments

Table 135. Mylan Company Information, Head Office, Market Area, and Industry Position

Table 136. Mylan Raibizumab Biosimilars Models, Specifications, and Application

Table 137. Mylan Raibizumab Biosimilars Sales Quantity (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin, 2020-2025

Table 138. Mylan Company Profile and Main Business

Table 139. Mylan Recent Developments

Table 140. BeiGene Company Information, Head Office, Market Area, and Industry Position

Table 141. BeiGene Raibizumab Biosimilars Models, Specifications, and Application

Table 142. BeiGene Raibizumab Biosimilars Sales Quantity (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin, 2020-2025

Table 143. BeiGene Company Profile and Main Business

Table 144. BeiGene Recent Developments

Table 145. Innovent Company Information, Head Office, Market Area, and Industry Position

Table 146. Innovent Raibizumab Biosimilars Models, Specifications, and Application

Table 147. Innovent Raibizumab Biosimilars Sales Quantity (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin, 2020-2025

Table 148. Innovent Company Profile and Main Business

Table 149. Innovent Recent Developments

Table 150. Qilu Pharmaceutical Company Information, Head Office, Market Area, and Industry Position

Table 151. Qilu Pharmaceutical Raibizumab Biosimilars Models, Specifications, and Application

Table 152. Qilu Pharmaceutical Raibizumab Biosimilars Sales Quantity (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin, 2020-2025

Table 153. Qilu Pharmaceutical Company Profile and Main Business

Table 154. Qilu Pharmaceutical Recent Developments

Table 155. Hengrui Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

Table 156. Hengrui Pharmaceuticals Raibizumab Biosimilars Models, Specifications, and Application

Table 157. Hengrui Pharmaceuticals Raibizumab Biosimilars Sales Quantity (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin, 2020-2025

Table 158. Hengrui Pharmaceuticals Company Profile and Main Business

Table 159. Hengrui Pharmaceuticals Recent Developments

Table 160. Hisun Pharmaceutical Company Information, Head Office, Market Area, and Industry Position

Table 161. Hisun Pharmaceutical Raibizumab Biosimilars Models, Specifications, and Application

Table 162. Hisun Pharmaceutical Raibizumab Biosimilars Sales Quantity (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin, 2020-2025

Table 163. Hisun Pharmaceutical Company Profile and Main Business

Table 164. Hisun Pharmaceutical Recent Developments

Table 165. TOT BIOPHARM Company Information, Head Office, Market Area, and Industry Position

Table 166. TOT BIOPHARM Raibizumab Biosimilars Models, Specifications, and Application

Table 167. TOT BIOPHARM Raibizumab Biosimilars Sales Quantity (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin, 2020-2025

Table 168. TOT BIOPHARM Company Profile and Main Business

Table 169. TOT BIOPHARM Recent Developments

Table 170. Luye Pharmaceutical Company Information, Head Office, Market Area, and Industry Position

Table 171. Luye Pharmaceutical Raibizumab Biosimilars Models, Specifications, and Application

Table 172. Luye Pharmaceutical Raibizumab Biosimilars Sales Quantity (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin, 2020-2025

Table 173. Luye Pharmaceutical Company Profile and Main Business

Table 174. Luye Pharmaceutical Recent Developments

Table 175. Henlius Company Information, Head Office, Market Area, and Industry Position

Table 176. Henlius Raibizumab Biosimilars Models, Specifications, and Application

Table 177. Henlius Raibizumab Biosimilars Sales Quantity (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin, 2020-2025

Table 178. Henlius Company Profile and Main Business

Table 179. Henlius Recent Developments

List of Figures

Figure 1. Raibizumab Biosimilars Picture

Figure 2. Global Raibizumab Biosimilars Consumption Value, (US$ million) & (2020-2031)

Figure 3. Global Raibizumab Biosimilars Sales Quantity, (Units) & (2020-2031)

Figure 4. Global Raibizumab Biosimilars Average Selling Price (ASP), (2020-2031) & (K USD/Unit)

Figure 5. China Raibizumab Biosimilars Consumption Value, (US$ million) & (2020-2031)

Figure 6. China Raibizumab Biosimilars Sales Quantity (Units) & (2020-2031)

Figure 7. China Raibizumab Biosimilars Average Selling Price (ASP), (K USD/Unit) & (2020-2031)

Figure 8. By Consumption Value, China Raibizumab Biosimilars Market Share of Global, 2020-2031

Figure 9. By Sales Quantity, China Raibizumab Biosimilars Market Share of Global, 2020-2031

Figure 10. Global Raibizumab Biosimilars Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2024

Figure 11. China Raibizumab Biosimilars Key Participants, Market Share, 2024

Figure 12. Global Raibizumab Biosimilars Capacity, Production and Capacity Utilization, 2020-2031

Figure 13. Global Raibizumab Biosimilars Capacity Market Share by Region, 2024 VS 2031

Figure 14. Global Raibizumab Biosimilars Production Market Share & Forecast by Region, 2020-2031

Figure 15. Raibizumab Biosimilars Industry Chain

Figure 16. Raibizumab Biosimilars Procurement Model

Figure 17. Raibizumab Biosimilars Sales Model

Figure 18. Raibizumab Biosimilars Sales Channels, Direct Sales, and Distribution

Figure 19. AMD

Figure 20. CNV

Figure 21. DME

Figure 22. by Type, Global Raibizumab Biosimilars Consumption Value, 2020-2031, US$ Million

Figure 23. by Type, Global Raibizumab Biosimilars Consumption Value Market Share, 2020-2031

Figure 24. by Type, Global Raibizumab Biosimilars Sales Quantity, 2020-2031, (Units)

Figure 25. by Type, Global Raibizumab Biosimilars Sales Quantity Market Share, 2020-2031

Figure 26. by Type, Global Raibizumab Biosimilars Average Selling Price (ASP), 2020-2031, (K USD/Unit)

Figure 27. ARMD

Figure 28. Diabetic Retinopathy

Figure 29. Macular Edema

Figure 30. by Application, Global Raibizumab Biosimilars Consumption Value, 2020-2031, US$ Million

Figure 31. by Application, Global Raibizumab Biosimilars Revenue Market Share, 2020-2031

Figure 32. by Application, Global Raibizumab Biosimilars Sales Quantity, 2020-2031, (Units)

Figure 33. by Application, Global Raibizumab Biosimilars Sales Quantity Market Share, 2020-2031

Figure 34. by Application, Global Raibizumab Biosimilars Price, 2020-2031, (K USD/Unit)

Figure 35. By Region, Global Raibizumab Biosimilars Consumption Value Market Share, 2020-2031

Figure 36. By Region, Global Raibizumab Biosimilars Sales Quantity Market Share, 2020-2031

Figure 37. North America Raibizumab Biosimilars Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 38. By Country, North America Raibizumab Biosimilars Consumption Value Market Share, 2024

Figure 39. Europe Raibizumab Biosimilars Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 40. By Country, Europe Raibizumab Biosimilars Consumption Value Market Share, 2024

Figure 41. Asia Pacific Raibizumab Biosimilars Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 42. By Country/Region, Asia Pacific Raibizumab Biosimilars Consumption Value Market Share, 2024

Figure 43. South America Raibizumab Biosimilars Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 44. By Country, South America Raibizumab Biosimilars Consumption Value Market Share, 2024

Figure 45. Middle East & Africa Raibizumab Biosimilars Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 46. United States Raibizumab Biosimilars Sales Quantity, 2020-2031, (Units)

Figure 47. by Type, United States Raibizumab Biosimilars Sales Quantity Market Share, 2024 VS 2031

Figure 48. by Application, United States Raibizumab Biosimilars Sales Quantity Market Share, 2024 VS 2031

Figure 49. Europe Raibizumab Biosimilars Sales Quantity, 2020-2031, (Units)

Figure 50. by Type, Europe Raibizumab Biosimilars Sales Quantity Market Share, 2024 VS 2031

Figure 51. by Application, Europe Raibizumab Biosimilars Sales Quantity Market Share, 2024 VS 2031

Figure 52. China Raibizumab Biosimilars Sales Quantity, 2020-2031, (Units)

Figure 53. by Type, China Raibizumab Biosimilars Sales Quantity Market Share, 2024 VS 2031

Figure 54. by Application, China Raibizumab Biosimilars Sales Quantity Market Share, 2024 VS 2031

Figure 55. Japan Raibizumab Biosimilars Sales Quantity, 2020-2031, (Units)

Figure 56. by Type, Japan Raibizumab Biosimilars Sales Quantity Market Share, 2024 VS 2031

Figure 57. by Application, Japan Raibizumab Biosimilars Sales Quantity Market Share, 2024 VS 2031

Figure 58. South Korea Raibizumab Biosimilars Sales Quantity, 2020-2031, (Units)

Figure 59. by Type, South Korea Raibizumab Biosimilars Sales Quantity Market Share, 2024 VS 2031

Figure 60. by Application, South Korea Raibizumab Biosimilars Sales Quantity Market Share, 2024 VS 2031

Figure 61. Southeast Asia Raibizumab Biosimilars Sales Quantity, 2020-2031, (Units)

Figure 62. by Type, Southeast Asia Raibizumab Biosimilars Sales Quantity Market Share, 2024 VS 2031

Figure 63. by Application, Southeast Asia Raibizumab Biosimilars Sales Quantity Market Share, 2024 VS 2031

Figure 64. India Raibizumab Biosimilars Sales Quantity, 2020-2031, (Units)

Figure 65. by Type, India Raibizumab Biosimilars Sales Quantity Market Share, 2024 VS 2031

Figure 66. by Application, India Raibizumab Biosimilars Sales Quantity Market Share, 2024 VS 2031

Figure 67. Middle East & Africa Raibizumab Biosimilars Sales Quantity, 2020-2031, (Units)

Figure 68. by Type, Middle East & Africa Raibizumab Biosimilars Sales Quantity Market Share, 2024 VS 2031

Figure 69. by Application, Middle East & Africa Raibizumab Biosimilars Sales Quantity Market Share, 2024 VS 2031

Figure 70. Research Methodology

Figure 71. Breakdown of Primary Interviews

Figure 72. Bottom-up Approaches

Figure 73. Top-down Approaches